NRXS
USDNeuraxis Inc. Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$2.660
Haut
$2.630
Bas
$2.520
Volume
0.12M
Fondamentaux de l'Entreprise
Capitalisation Boursière
25.4M
Industrie
Biotechnologie
Pays
United States
Statistiques de Trading
Volume Moyen
0.38M
Bourse
ASE
Devise
USD
Intervalle sur 52 Semaines
Actualités Connexes
NeurAxis to Host Third Quarter 2025 Results and Business Update Call on Tuesday, November 11, 2025
CARMEL, Ind., Nov. 04, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE:NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating
NeurAxis Awarded First Ever FDA Clearance for the Treatment of Pain in Functional Dyspepsia (FD) with associated Nausea Symptoms in the Adult Patient Population
Achieves significant expansion of NeurAxis' total addressable marketClearance now includes patients aged "8 years and older"Expanded age indication will utilize the upcoming January 1st, 2026, Category I CPT code to
Actions Connexes
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.